Stimlabs LLC – Trademark Portfolio
Entity Type: 16
Stimlabs LLC holds 25 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 5 Nice Classification classes. Currently, 13 trademarks are registered and 4 are pending. Notable registered marks include ASCENT, RELESE, REVITA, COGENEX, and CORPLEX. The owner is based in Roswell, GA.
Suite 104
1225 Northmeadow Parkway
Roswell, GA 30076
Showing of trademarks Trademarks
Trademark Classifications
Stimlabs LLC's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Stimlabs LLC have?
Stimlabs LLC has 25 U.S. trademarks filed with the USPTO. Of these, 13 registered, 4 pending, 8 abandoned.
What trademark classes does Stimlabs LLC file in?
Stimlabs LLC files trademarks across 5 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Stimlabs LLC's most well-known trademarks?
Stimlabs LLC's registered trademark portfolio includes well-known marks such as ASCENT, RELESE, REVITA, COGENEX, and CORPLEX. These are among 13 currently registered trademarks in the portfolio.
What is Stimlabs LLC's trademark registration success rate?
Stimlabs LLC has a 62% trademark registration rate, with 13 out of 21 resolved applications resulting in successful registration. Currently, 4 applications are pending review.